DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sun Pharma Share Price Live Updates: Sun Pharma's Market Update

Economic Times 4 hrs ago·7 Sept 2026, 2:31 am

Sun Pharma's stock is currently in focus as the company updates investors on its market performance. This live coverage tracks the latest movements in the share price and any significant announcements affecting the stock.

For investors, these updates are crucial for understanding the company's current standing and the factors driving its valuation. Keeping an eye on the latest developments helps retail investors gauge the company's health and make informed decisions regarding their portfolio.

Moving forward, market participants should watch for any official statements from the company regarding its financial outlook or strategic initiatives. These factors will likely play a key role in determining the stock's future trajectory.